Psycho-Oncology · 2012 · 92 citations · 27 references
Below average cognitive performance is common in this patient group. In addition, a subgroup shows reliable cognitive decline after allogeneic HSCT. Healthcare professionals should be aware of these treatment-related cognitive side effects.
27
Cognitive function during neoadjuvant chemotherapy for breast cancer
Kerstin Hermelink, Michael Untch, Michael P. Lux et al. · Cancer · 2007 · 352 citations · Full text